No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 1, 2005, Pages 1-6

  Bozikas, Vasilis P ^b   Niopas, Ioannis ^a   Kafantari, Anna ^a   Kanaze, Feraz Imad ^a   Gabrieli, Chrysi ^a   Melissidis, Petros ^a   Gamvrula, Katerina ^a   Fokas, Kostas ^a   Karavatos, Athanasios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Greece ^*  (Greece)

Author keywords

Metabolism; Nicotine; Schizophrenia; Smoking

Indexed keywords

COTININE; NICOTINE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; URINALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COTININE; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SCHIZOPHRENIA; SMOKING;

EID: 10944242714     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.08.002     Document Type: Article

References (47)

1. L.E. Adler, L.J. Hoffer, J. Griffith, M.C. Waldo, and R. Freedman Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics Biol. Psychiatry 32 1992 607 616
2. L.E. Adler, L.D. Hoffer, A. Wiser, and R. Freedman Normalization of auditory physiology by cigarette smoking in schizophrenic patients Am. J. Psychiatry 150 1993 1856 1861
3. American Psychiatric Association DSM-IV: Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Press Washington, DC
4. N.L. Benowitz, and P. Jacob III Nicotine and nicotine elimination pharmacokinetics in smokers and nonsmokers Clin. Pharmacol. Ther. 53 1993 316 323
5. S. Beratis, A. Katrivanou, and P. Gourzis Factors affecting smoking in schizophrenia Compr. Psychiatry 42 2001 393 402
6. C.R. Breese, M.J. Lee, C.E. Adams, B. Sullivan, J. Logel, K.M. Gillen, M.J. Marks, A.C. Collins, and S. Leonard Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia Neuropsychopmacology 23 2000 351 364
7. K.S. Cadenhead, and D.L. Braff Information processing and attention in schizophrenia: clinical and functional correlates and treatment of cognitive impairment T. Sharma P. Harvey Cognition in Schizophrenia: Impairment, Importance and Treatment Strategies 2000 92 125 New York
8. G.W. Dalack, D.J. Healy, and J.H. Meador-Woodruff Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings Am. J. Psychiatry 155 1998 1490 1501
9. J.A. Dani Overview of nicotine receptors and their roles in the central nervous system Biol. Psychiatry 49 2001 166 174
10. J. de Leon, M. Dadvand, C. Canuso, A.O. White, J.K. Stanilla, and G.M. Simpson Schizophrenia and smoking: an epidemiological survey in a state hospital Am. J. Psychiatry 152 1995 453 455
11. S. de Weerd, C.M.G. Thomas, J.E.T.G. Kuster, R.J.L.M. Cikot, and E.A.P. Steegers Variation of serum and urine cotinine in passive and active smokers and applicability in preconceptional smoking cessation counseling Environ. Res. 90 2002 119 124
12. A. Diwan, M. Castine, C.S. Pomerleau, J.H. Meador-Woodruff, and G.W. Dalack Differential prevalence of cigarette smoking in patients with schizophrenic vs. mood disorders Schizophr. Res. 33 1998 113 118
13. R.P.K. Ford, D.M. Tappin, P.J. Schluter, and C.J. Wild Smoking during pregnancy: how reliable are maternal self reports in New Zealand? J. Epidemiol. Community Health 51 1996 246 251
14. R. Freedman, M. Hall, L.E. Adler, and S. Leonard Evidence of postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia Biol. Psychiatry 38 1995 22 33
15. D.C. Goff, D.C. Henderson, and E. Amico Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects Am. J. Psychiatry 149 1992 1189 1194
16. A. Herrán, A. de Santiago, M. Sandoya, M.J. Fernández, J.F. Díez-Manrique, and J.L. Vázquez-Barquero Determinants of smoking behaviour in outpatients with schizophrenia Schizophr. Res. 41 2000 373 381
17. J.R. Hughes, D.K. Hatsukami, J.E. Mitchell, and L.A. Dahlgren Prevalence of smoking among psychiatric outpatients Am. J. Psychiatry 143 1986 993 997
18. M.J. Jarvis, M.A. Russell, N.L. Benowitz, and C. Feyerabend Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure Am. J. Public Health 78 1988 696 698
19. C. Kelly, and R.G. McCreadie Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland Am. J. Psychiatry 156 1999 1751 1757
20. V. Kumari, and T. Sharma Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research Psychopharmacology 162 2002 97 101
21. V. Kumari, W. Soni, and T. Sharma Normalization of information processing deficits in schizophrenia with clozapine Am. J. Psychiatry 156 1999 1046 1051
22. V. Kumari, W. Soni, and T. Sharma Influence of cigarrete smoking on prepulse inhibition of the acoustic startle response in schizophrenia Hum. Psychopharmacol. 16 2001 321 326
23. V. Kumari, W. Soni, and T. Sharma Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics Schizophr. Res. 55 2002 139 146
24. S. Leonard, C. Breese, C. Adams, K. Benhammou, J. Gault, K. Stevens, M. Lee, L. Adler, A. Olincy, R. Ross, and R. Freedman Smoking and schizophrenia: abnormal nicotinic receptor expression Eur. J. Pharmacol. 393 2000 237 242
25. L. Leumann, J. Feldon, F.X. Vollenweider, and K. Ludewig Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia Biol. Psychiatry 52 2002 729 739
26. G.A. Light, M.A. Geyer, B.A. Clementz, K.S. Cadenhead, and D.L. Braff Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medication Am. J. Psychiatry 157 2000 767 771
27. R. Lindqvist, L. Lendahls, Ö. Tollbom, H. Åberg, and A. Håkansson Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women Acta Obstet. Gynecol. Scand. 81 2002 240 244
28. J.B. Lohr, and K. Flynn Smoking and schizophrenia Schizophr. Res. 8 1992 93 102
29. E.R. Lyon A review of the effects of nicotine on schizophrenia and antipsychotic medications Psychiatr. Serv. 50 1999 1346 1350
30. T. Mackeprang, K.T. Kristiansen, and B.Y. Glenthoj Effects of antipsychotics on prepulse inhibition of the startle response in drug naïve schizophrenic patients Biol. Psychiatry 52 2002 863 873
31. E. Masterson, and B. O'Shea Smoking and malignancy in schizophrenia Br. J. Psychiatry 145 1984 429 432
32. H.T. Nagamoto, L.E. Adler, R.A. Hea, J.M. Griffith, K.A. McRae, and R. Freedman Gating of auditory P50 in schizophrenics: unique effects of clozapine Biol. Psychiatry 40 1996 181 188
33. H.T. Nagamoto, L.E. Adler, K.A. McRae, P. Huettl, E. Cawthra, G. Gerhardt, R.A. Hea, and J.M. Griffith Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol Neuropsychobiology 39 1999 10 17
34. M. Nakajima, T. Yamamoto, Y. Kuroiwa, and T. Yokoi Improved highly sensitive method for the determination of nicotine and cotinine in human plasma by high-performance liquid chromatography J. Chromatogr., B, Biomed. Sci. Appl. 742 2000 211 215
35. A. Olincy, D.A. Young, and R. Freedman Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers Biol. Psychiatry 42 1997 1 5
36. A. Olincy, R.G. Ross, D.A. Young, M. Roath, and R. Freedman Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients Neuropsychopharmacology 18 1998 175 185
37. A. Olincy, L.L. Johnson, and R.G. Ross Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia Psychiatry Res. 117 2003 223 236
38. P. Postma, J.A. Gray, V. Kumari, W. Soni, E. Zachariah, R. Mehrotra, M. Das, M. Hines, and T. Sharma Effects of nicotine on prepulse inhibition in people with schizophrenia Int. J. Neuropsychopharmacol. 3 Suppl. 1 2000 S109
39. J.E. Rose, F.M. Behm, E.C. Westman, R.J. Mathew, E.D. London, T.C. Hawk, T.G. Turkington, and R.E. Coleman PET studies of the influences of nicotine on neural systems in cigarette smokers Am. J. Psychiatry 160 2003 323 333
40. B. Schilström, N. Rawal, M. Mameli-Engvall, G.G. Nomikos, and T.H. Svensson Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes Int. J. Neuropsychopharmacol. 6 2003 1 11
41. M.J. Seaton, and E.S. Vessel Variables affecting nicotine metabolism Pharmacol. Ther. 60 1993 461 500
42. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G.C. Dunbar The Mini-International Neuropsychiatric (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J. Clin. Psychiatry 59 Suppl. 20 1998 22 33
43. B. Spring, R. Pingitore, and D.E. McChargue Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers Am. J. Psychiatry 160 2003 316 322
44. A.R. Tricker Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour Toxicology 183 2003 151 173
45. M. Yang, N. Kunugita, K. Kitagawa, S.H. Kang, B. Coles, F.F. Kadlubar, T. Katoh, K. Matsumo, and T. Kawamoto Individual difference in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes Cancer Epidemiol. Biomark. Prev. 10 2001 589 593
46. C.M. Yee, K.H. Nuechterlein, S.E. Morris, and P.M. White P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects J. Abnorm. Psychology 107 1998 691 698
47. P. Zuccaro, I. Altieri, M. Rosa, A.R. Passa, S. Pichini, and R. Pacifici Solid-phase extraction of nicotine and its metabolites for high-performance liquid chromatographic determination in urine J. Chromatogr., B, Biomed. Sci. Appl. 668 1995 187 188